A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma. (25th September 2015)

Record Type:: Journal Article
Title:: A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma. (25th September 2015)
Main Title:: A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma
Authors:: Rosenthal, Allison
Kumar, Shaji
Hofmeister, Craig
Laubach, Jacob
Vij, Ravi
Dueck, Amylou
Gano, Katherine
Stewart, A. Keith
Abstract:
Is Part Of:: British journal of haematology. Volume 174:Number 2(2016)
Journal:: British journal of haematology
Issue:: Volume 174:Number 2(2016)
Issue Display:: Volume 174, Issue 2 (2016)
Year:: 2016
Volume:: 174
Issue:: 2
Issue Sort Value:: 2016-0174-0002-0000
Page Start:: 323
Page End:: 325
Publication Date:: 2015-09-25
Subjects:: multiple myeloma -- alisertib -- aurora kinase -- bortezomib -- relapse
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.13765 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1067.xml